Program

Symposium

President Lecture

Vetue No. Theme Chair Speaker Title
May 19 (Thursday) 12:55-13:40
Room1(Kobe International Exhibition Hall [Convention Hall] Hall No.2 Building 1F) Pr President Lecture Jun Kimura (Department of Neurology, University of Iowa Health Care, USA) Ryuji Kaji (Department of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School) Toward Treatable Neurology

Plenary Lecture

Vetue No. Theme Chair Speaker Title
May 18 (Wednesday) 18:30-19:00
Room1(Kobe International Exhibition Hall [Convention Hall] Hall No.2 Building 1F) PL-01 Plenary Lecture 01 Ryuji Kaji (Department of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School) Stanley Fahn (Columbia University Medical Center) Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
May 18 (Wednesday) 19:00-19:30
Room1(Kobe International Exhibition Hall [Convention Hall] Hall No.2 Building 1F) PL-02 Plenary Lecture 02 Hiroshi Shibasaki (Faculty of Medicine Kyoto University) Mark Hallett (NINDS, NIH) Diagnosis and Management of Functional (Psychogenic) Movement Disorders

Semi-Plenary Lecture

Vetue No. Theme Chair Speaker Title
May 19 (Thursday) 16:10-16:50
Room1(Kobe International Exhibition Hall [Convention Hall] Hall No.2 Building 1F) SPL-01 Semi-Plenary Lecture 01 Satoshi Kuwabara (Department of Neurology, Chiba University) Austin J. Sumner (LSU Health Sciences Center) CONDUCTION BLOCK
May 20 (Friday) 13:40-14:10
Room1(Kobe International Exhibition Hall [Convention Hall] Hall No.2 Building 1F) SPL-02 Semi-Plenary Lecture 02 Shigeki Kuzuhara (Faculty of Health Science, Suzuka University of Medical Science) Raad Shakir (Brain Science Imperial College London UK) Neurology Atlas 2015 WHO/WFN COLLABORATION
May 20 (Friday) 14:10-14:40
Room1(Kobe International Exhibition Hall [Convention Hall] Hall No.2 Building 1F) SPL-03 Semi-Plenary Lecture 03 Hidehiro Mizusawa (National Center Hospital National Center of Neurology and Psychiatry) Terrence Lawrence Cascino (American Academy of Neurology) American Academy of Neurology: Enhancing International Relationships

Neuroscience Frontier Symposium

Vetue No. Theme Chair Speaker Title
May 19 (Thursday) 8:00-10:00
Room9(Kobe Portopia Hotel[Kairaku 3] Main Building B1F) NF-01 Next-generation neurogenetics: cutting-edge strategies for understanding neurological disorders Masashi Aoki (Department of Neurology, Tohoku University School of Medicine) / Yuji Takahashi (Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry) Yuji Takahashi (Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry) Impact of next-generation sequencing on deciphering ALS pathogenesis
Matthew Harms (Department of Neurology, Columbia University/Institute for Genomic Medicine, Columbia University) The Genetics of Amyotrophic Lateral Sclerosis: Past Success, Current Challenges, Future Directions
Naoki Atsuta (Department of Neurology, Nagoya University Hospital) Genetic aspects of sporadic ALS based on JaCALS cohort study
Bing-Wen Soong (Medicine, Section of Neurology, National Yang-Ming University and Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan) Next generation sequencing-based diagnoses of neurological disorders
Wataru Satake (Div Neurol, Kobe Univ) Genetics-based approach for understanding Parkinson's disease
May 21 (Saturday) 8:00-10:00
Room10(Kobe International Conference Center[Main Hall] B1F・1F) NF-02 Therapeutic strategies, mechanisms of spreading of α-synuclein, and biomarkers of Parkinson's disease Nobutaka Hattori (Department of Neurology, Juntendo University School of Medicine) / Hidefumi Ito (Department of Neurology, Wakayama Medical University) Seung-Jae Lee (Department of Biomedical Sciences, Seoul National University College of Medicine) Critical evaluation of the proteotoxin paradigm of neurodegenerative diseases
Makio Takahashi (Department of Neurology, Japan Red Cross Osaka Hospital) Morphological and biological mechanisms of alpha-synuclein spreading in Parkinson's disease
Shinji Saiki (Department of Neurology, Juntendo University Graduate School of Medicine) Blood biomarkers of Parkinson's disease

Toward Treatable Neurology

Vetue No. Theme Chair Speaker Title
May 18 (Wednesday) 13:15-15:15
Room8(Kobe Portopia Hotel[Kairaku 2] Main Building B1F) TN-02
Co-host: The Japan Neuroscience Society
Current topics in myotonic dystrophy - advance in disease machanism and emerging clinical issues Masanori Takahashi (Department of Neurology, Osaka University Graduate School of Medicine) / Tohru Matsuura (Division of Neurology, Department of Medicine Jichi Medical University) Tetsuo Ashizawa (Methodist Hospital Research Institute) Myotonic dystrophy type 1 - potential pitfalls in therapeutic development
Ruriko Kitao (Department of Neurology, Hakone Hospital) Newly identified Japanese DM2 pedigree
Mitsuru Kawamura (Department of Neurology, Showa University School of Medicine) Social cognitive impairment in myotonic dystrophy type 1.
Yasushi Iwasaki (Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University) Brain pathology of the myotonic dystrophy
Kuang-Yung Lee (Department of Molecular Genetics and Microbiology, Center for NeuroGenetics and the Genetics Institute, University of Florida, College of Medicine, Gainesville, Florida, USA/Department of Neurology, Chang Gung Memorial Hospital, Keelung,Taiwan/School of Medicine, Chang Gung University, Taoyuan, Taiwan) Muscleblind-like double knockout mice for modeling myotonic dystrophy
May 19 (Thursday) 8:00-10:00
Room2(Kobe International Exhibition Hall[Exhibition Hall A] Hall No.1 Building 2F) TN-04 Acute treatment and secondary prevention of stroke:The breaking evidences Yoshiaki Itoh (Dept Neurology, Osaka City University Graduate School of Medicine) / Haruhiko Hoshino (Department of Neurology, Tokyo Saiseikai Central Hospital) Shigeru Nogawa (Department of Neurology, Tokai University Hachioji Hospital) Medical treatment for acute ischemic stroke - IV t-PA in Japan and issues to be discussed
Stephen Davis (University of Melbourne/Melbourne Brain Centre at Royal Melbourne Hospital) Endovascular therapy for acute ischemic stroke: future directions
Naohisa Hosomi (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical & Health Sciences) Management of Dyslipidemia for Stroke Prevention
Teruyuki Hirano (Department of Stroke and Cerebrovascular Medicine, Kyorin University) Oral anticoagulant therapy for prevention of cardioembolism
Room10(Kobe International Conference Center[Main Hall] B1F・1F) TN-05 Recent advance of Clinical trials and treatment in progressive supranuclear palsy Ikuko Aiba (Department of Neurology, National Hospital Organization, Higashi Nagoya National Hospital) / Kenji Nakashima (Division of Neurology, Department of Brain and Neurosciences Faculty of Medicine, Tottori University) Masato Kanazawa (Department of Neurology, Brain Research Institute, Niigata University) Broad phenotypic spectrum and symptomatic treatments of progressive supranuclear palsy
Shunsuke Koga (Department of Neuroscience, Mayo Clinic) Clinicopathologic study on progressive supranuclear palsy with cerebellar ataxia in the US
Hitoshi Shimada (Molecular Imaging Center, National Institute of Radiological Sciences) Current status and issues of clinical application of tau PET in progressive supranuclear palsy
Adam L. Boxer (University of California, San Francisco) Targeting Tauopathies for Tau Therapeutic Translation
May 19 (Thursday) 15:15-17:15
Room10(Kobe International Conference Center[Main Hall] B1F・1F) TN-06 Improvement in the management of Parkinson's disease: Present status and prospect of ultra-early diagnosis Kazushi Takahashi (Department of Neurology, Saitama Medical University) / Hirohisa Watanabe (Nagoya University, Brain and Mind Research Center) David J. Burn (Institute of Neuroscience, Newcastle University) Diagnosing Parkinson disease. When and how.
Eng-King Tan (National Neuroscience Institute/Duke NUS Graduate Medical School) Motor and non motor features of prodromal & early stage genetic forms of Parkinson disease
Satoshi Orimo (Department of Neurology, Kanto Central Hospital) Nuclear neuroimaging: Potential diagnostic value of SPECT and PET
Epifanio Bagarinao (Brain and Mind Research Center, Nagoya University) Novel neuroimaging approaches for exploring cerebral functional and anatomical connectivity

HotTopix

Vetue No. Theme Chair Speaker Title
May 18 (Wednesday) 9:50-11:50
Room4(Kobe International Exhibition Hall[Room 3A] Hall No.2 Building 3F) HT-02 Myasthenia gravis: New insights and overview Naoko Matsui (Department of Neurology, Tokushima University Hospital) / Tomihiro Imai (Sapporo Medical University School of Health Sciences) Tomihiro Imai (Sapporo Medical University School of Health Sciences) Perspective in the study of Japanese Clinical Guideline and overview
Hiroaki Yoshikawa (Kanazawa University Health Service Center) Thymectomy in Non-thymomatous Myasthenia Gravis: MGTX study a Randomized, Controlled Trial
Akiyuki Uzawa (Department of Neurology, Graduate School of Medicine, Chiba University) Inflammatory Markers of Myasthenia Gravis
Alexander Marx (University of Heidelberg) Intrathymic pathogenesis in various Myasthenia Gravis (MG) subgroups
Naoko Matsui (Department of Neurology, Tokushima University Hospital) Approach from T cell development in MG thymus
Room5(Kobe International Exhibition Hall[Room 2A] Hall No.2 Building 3F) HT-03 Cutting edge of metabolic/hereditary neuropathies Satoshi Kuwabara (Department of Neurology, Chiba University) / Haruki Koike (Department of Neurology, Nagoya University Graduate School of Medicine) Yoshiki Sekijima (Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine) Cutting-edge therapies for amyloid neuropathy
Masanori Nakagawa (North Medical Center, Kyoto Prefectural University of Medicine) Therapeutic strategy for Charcot-Marie-Tooth disease
Sonoko Misawa (Department of Neurology, Graduate School of Medicine, Chiba University) Current therapeutic strategies for POEMS syndrome
Susanna B. Park (Brain and Mind Centre, University of Sydney) Chemotherapy-induced Peripheral Neuropathy: From Pathophysiology to Neuroprotection
May 19 (Thursday) 8:00-10:00
Room14(Kobe International Conference Center[Meeting Room 501] 5F) HT-06 Neuroregeneration and nucleic acid medicine Hideyuki Okano (Keio University School of Medicine Department of Physiology) / Masayuki Nakamori (Dept. of Neurology, Osaka University Graduate School of Medicine) Frank Bennett (IONIS Pharmaceuticals) Antisense Oligonucleotide Therapies for the Treatment of Neurodegenerative Diseases
Kazutaka Nishina (Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University) Novel oligonucleotide based on DNA/RNA heteroduplex structures
Dong-ki Lee (Department of Chemistry, Sungkyunkwan University) Therapeutic development using cell penetrating, asymmetric RNAi triggers
Kazunobu Sawamoto (Department of Developmental and Regenerative Biology, Nagoya City University Graduate School of Medical Sciences) Migration and maturation of new neurons in the normal and injured adult brain
Seiji Hitoshi (Department of Integrative Physiology, Shiga University of Medical Science) The role of adult neural stem cell-neurogenesis in the pathogenesis of psychiatric disorders
Tatsunori Seki (Department of Histology and Neuroanatomy, Tokyo Medical University) Unique embryonic neurogenesis in the hippocampus, an adult neurogenic region
May 19 (Thursday) 15:15-17:15
Room6(Kobe International Exhibition Hall[Room 3B] Hall No.2 Building 3F) HT-08 Molecular dissection of Hereditary Spastic Paraplegia Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan) / Hiroyuki Ishiura (Department of Neurology, The University of Tokyo) Craig Blackstone (NINDS, US National Institutes of Health) Emerging genetic and cellular insights into HSP pathogenesis
Kishin Koh (Department of Neurology, University of Yamanashi) Molecular epidemiology of HSPs in Japan
Chin-Song Lu (Chang Gung Medical Center at Linkou and Chang Gung University) Genetic Analysis in a Cohort of Taiwanese Patients with Hereditary Spastic Paraplegia
Hiroyuki Ishiura (Department of Neurology, The University of Tokyo) Strategies for identifying causative genes of HSP
Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan) A Homozygous loss-of-function mutation in DNAJA3 causes HMSN type V
May 19 (Thursday) 15:15-16:55
Room15(Kobe International Conference Center[Meeting Room502] 5F) HT-09 Combining imaging and therapy: Neuroimaging-based companion diagnostics and theranostics Makoto Higuchi (Molecular Imaging Center, National Institute Radiological Sciences) / Makoto Yoneda (Faculty of Nursing and Social Welfare Sciences Fukui Prefectural University) Shin-ichi Muramatsu (Division of Neurology, Jichi Medical University/Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo) In vivo monitoring of AADC gene delivery by PET
Michael D. Devous (Vice President, Avid Radiopharmaceuticals, Inc.) The Role of Amyloid and Tau Imaging in Clinical Trials in Alzheimer's Disease
Masahiro Mishina (Department of Neuro-pathophysiological imaging, Graduate School of Medicine, Nippon Medical School/Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology) Imaging and treatment targeting adenosine receptors in Parkinson's disease
Bin Ji (National Institute of Radiological Sciences) In vivo Imaging for Monitoring Differentiation and Manipulating Function of iPS Cells
May 20 (Friday) 8:00-10:00
Room8(Kobe Portopia Hotel[Kairaku 2] Main Building B1F) HT-12
Co-host: Asian Pacific Society of Prion Research
Expanding prion concept to cerebral beta-amyloidosis and alpha-synucleinopathies Masahito Yamada (Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences) / Takeshi Iwatsubo (Department of Neuropathology Graduate School of Medicine The University of Tokyo) Atsushi Kobayashi (Graduate School of Veterinary Medicine, Hokkaido University) Mechanisms of transmission of prion diseases
Mathias Jucker (Hertie Institute for Clinical Brain Research, University of Tübingen, Germany/German Center for Neurodegenerative Diseases, Tübingen, Germany) Propagation and spreading of Alzheimer lesions
Tsuyoshi Hamaguchi (Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science) Possible iatrogenic transmission of cerebral beta-amyloidosis
Seung-Jae Lee (Department of Biomedical Sciences, Seoul National University College of Medicine) Progression mechanism of synucleinopathies
Room13(Kobe International Conference Center[Meeting Rooms 401+402] 4F) HT-13 Understanding ALS pathogenesis by Updated progress in C9ORF72-TDP43 lineage Takanori Yokota (Department of Neurology and Neurological Science, Tokyo Medical and Dental University) / Makoto Urushitani (Department of Neurology, Kyoto University Graduate School of Medicine) Hitoshi Takahashi (Department of Pathology, Brain Research Institute, Niigata University) Amyotrophic lateral sclerosis and C9ORF72/TDP-43 pathology
Suzuki Naoki (Department of Neurology, Tohoku University/Department of Stem Cell and Regenerative Biology, Harvard University) Deciphering the expression and function of C9ORF72 using mouse model
Yoshitsugu Aoki (Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry) C9orf72-Rab mediates defective vesicle trafficking in C9ALS/FTD and rescue by antisense intervention
Makoto Urushitani (Department of Neurology, Kyoto Graduate School of Medicine) Impaired VHL/CUL2-mediated clearance of misfolded TDP-43 underlies oligodendrocyte inclusions in ALS
Leonard Petrucelli (Mayo Clinic) (TBA)
May 20 (Friday) 13:15-14:55
Room8(Kobe Portopia Hotel[Kairaku 2] Main Building B1F) HT-15 Gene therapy & regenerative medicine Hideki Mochizuki (Department of Neurology, Osaka University Graduate School of Medicine) / Haruhisa Inoue (Center for IPS Cell Research and Application, Dept.of Cell Growth and Differentiation) Krystof Bankiewicz (Neurosurgery and Neurology, University of California San Francisco, CA, USA) MRI-based Platform for AAV2-GDNF and AAV-2AADC Gene Delivery in Parkinson's disease.
Jun Takahashi (Kyoto University, Center for iPS Cell Research and Application) Cell-Based Therapeutics for Parkinson's disease
Masayuki Nakamori (Dept. of Neurology, Osaka University Graduate School of Medicine) Gene therapy with antisense oligonucleotides for neurological and neuromuscular disorders
Ryoichiro Kageyama (Kyoto University, Institute for Virus Research/Kyoto University, WPI-iCeMS) Oscillatory control of proliferation and differentiation of neural stem cells
May 20 (Friday) 13:15-15:15
Room10(Kobe International Conference Center[Main Hall] B1F・1F) HT-17 Translational approach for prevention and treatment of MS Takashi Yamamura (Department of Immunology, National Institute of Neuroscience, NCNP) / Takayuki Kondo (Department of Clinical Network and Collaborative Medicine Kyoto University) Ralf Gold (Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum) IMPACT OF NUTRITION ON CNS AUTOIMMUNITY AND THEIR THERAPEUTIC POTENTIAL FOR MULTIPLE SCLEROSIS
Sachiko Miyake (Department of Immunology,Juntendo University School of Medicine) Alterations in gut flora giving clues to the cure of MS
Daisuke Noto (Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)/Department of Immunology, Juntendo University Graduate School of Medicine) Investigator-Initiated Clinical Trial (first-in-human, Phase I) of invariant NKT cell ligand OCH
Ho Jin Kim (Department of Neurology, National Cancer Center, Korea) Current and future treatment for multiple sclerosis
Masakazu Nakamura (Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan/Department of Neurology, Hokkaido Medical Center, Sapporo, Japan) IL-6 signal blockade for CNS autoimmune diseases

Asia Initiative Session

Vetue No. Theme Chair Speaker Title
May 19 (Thursday) 8:00-10:00
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) AI-01 Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) in Asia Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School) / Elahe Elahi (Department of Biotechnology, College of Science, University of Tehran) Toshitaka Kawarai (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima city, Japan) Clinicopathological features of HMSN-P in the Kansai area of Japan
Masahito Suehara (Neurology, Fujimoto General Hospital of Fujimoto Medical System) HMSN-P in the Okinawa islands of Japan; clinical-epidemiological-neurophysiological findings
Byung-ok Choi (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Proximal dominant hereditary motor and sensory neuropathy in Korean patients with TFG mutation
Elahi Elahe (College of Science, University of Tehran) Iranian patients affected with familial forms of neuromuscular disorders with mutations in TFG
Ryosuke Oki (Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan) Animal model of HMSN-P
Nagahisa Murakami (Center for iPS Cell Research and Application (CiRA), Kyoto University/Department of Clinical Neuroscience, Institute of Health Biosciences, Tokushima University Graduate School) Modeling HMSN-P motor neurons using patient iPSCs with mutant TFG
May 19 (Thursday) 15:15-17:15
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) AI-02 X-linked Dystonia Parkinsonism Lillian V. Lee (Philippine Children's Medical Center) / Tatsushi Toda (Division of Neurology Kobe University Graduate School of Medicine) Lillian V. Lee (Philippine Children's Medical Center) Clinical Picture of X-Linked Dystonia Parkinsonism (XDP)
David Eidelberg (The Feinstein Institute for Medical Research) Abnormal visual motion perception pathways in primary dystonia
Ryosuke Miyamoto (Department of Neurology, Tokushima University Hospital) Genetics of X-linked Dystonia Parkinsonism
Ryoma Morigaki (Parkinson's Disease and Dystonia Research Center, Tokushima University Hospital/Department of Neurosurgery, Institute of Biomedical Sciences, Graduate School of Medical Sciences, Tokushima University) Neuropathology of X-linked dystonia parkinsonism
Tatsushi Toda (Division of Neurology / Molecular Brain Science Kobe University Graduate School of Medicine) Gene Therapy for Transposon Disease

East Asian Neurology Forum

Vetue No. Theme Chair Speaker Title
May 20 (Friday) 13:15-15:45
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) EANF How to Manage Stroke:the first priority in Asia Session 1
Joung-Ho Rha (Inha University Hospital Neurology, Incheon) / Giia-Sheun Peng (Taipei Veteran General Hospital, Hsinchu Branch)
Yasuhiro Hasegawa (Department of Neurology, St. Marianna University School of Medicine) Prevention of Stroke - From risk factor to biomarker -
Kwon Sun-Uck (Asan Medical Center Neurology) Secondary Stroke Prevention in Asian Patients
Woong Yoon (Department of Radiology, Chonnam National University Hospital) Stent Retriever Thrombectomy for Treatment of Acute Ischemic Stroke
Session 2
Liyung Cui (Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) / Kazuo Kitagawa (Department of Neurology, Tokyo Women's Medical University)
Liyung Cui (Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College/Neuroscience center, Chinese Academy of Medical Sciences) Secondary Prevention of ischemic Stroke in China
Jiann-Shing Jeng (Taipei Veteran General Hospital, Hsinchu Branch) Quality improvement of Acute Stroke Care in Taiwan
K.S. Lawrence Wong (Department of Medicine & Therapeutics, Chinese University of Hong Kong) Acute Phase Management of Stroke
Raymond Lotilla Rosales (University of Santo Tomas Hospital, Manila, Philippines) Botulinum Toxin Therapy in Post-Stroke Spasticity: The Forward Steps

Symposium

Vetue No. Theme Chair Speaker Title
May 18 (Wednesday) 13:15-15:15
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) S-03 Movement disorders update Kazuko Hasegawa (Department of Neurology, National Hospital Organization, Sagamihara National Hospital) / Takashi Sakamoto (Department of Neurology, National Center of Neurology and Psychiatry) David J. Burn(Institute of Neuroscience, Newcastle University) Recent advances in Parkinson disease: Hyperbole or hope?
Ritsuko Hanajima(Department of Neurology, Kitasato University School of Medicine) Update on Tremor
Yoshikazu Ugawa(Fukushima Medical University) What's Dystonic tremor?
Kazuko Hasegawa(Department of Neurology, National Hospital Organization, Sagamihara National Hospital) Huntington's disease-update
Room13(Kobe International Conference Center[Meeting Rooms 401+402] 4F) S-04 Biomarkers and progression of motor neuron disease Hirofumi Maruyama (Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences) / Masahisa Katsuno (Department of Neurology, Nagoya University Graduate School of Medicine) Hiroshi Mitsumoto(Eleanor and Lou Gehrig MDA/ALS Center, Department of Neurology, Columbia University Medical Center) Biomarkers of Disease Progression in ALS
Naoko Takamatsu(Department of Neurology, Tokushima University Hospital) Recent advances in neuromuscular ultrasound in ALS
Hirohisa Watanabe (Nagoya University, Brain and Mind Research Center/Department of Neurology, Nagoya University Graduate School of Medicine) Neural network disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Masahisa Katsuno (Department of Neurology, Nagoya University Graduate School of Medicine) Application of biomarkers for early-stage of spinal and bulbar muscular atrophy to clincal trials
Yuta Iwai (Department of Neurology, Graduate School of Medicine, Chiba University) Axonal dysfunction precedes motor neuronal death in amyotrophic lateral sclerosis
Room14(Kobe International Conference Center[Meeting Room 501] 5F) S-05 Neuro-oncology update---Roles of neurologists--- Hidehiro Mizusawa (National Center Hospital National Center of Neurology and Psychiatry) / Masatoyo Nishizawa (Department of Neurology, Clinical Neuroscience Branch Brain Research Institute, Niigata University) Wolfgang Grisold (Dept Neurol, Kaiser Franz Josef Hospital, Vienna, Austria) Neurooncology and Neurology
Joon H. Uhm (Department of Neurology, Mayo Clinic) Neuro-oncology in the 21st century: Exciting advances in new and effective therapies
Akitake Mukasa (Department of Neurosurgery, The University of Tokyo Hospital) A multidisciplinary approach to the treatment of brain tumors
Nobuo Sanjo (Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences) Various neurological manifestations of lymphoma
May 19 (Thursday) 8:00-10:00
Room7(Kobe Portopia Hotel[Kairaku 1] Main Building B1F) S-07 Disruption of glia-neuron assemblies in intractable neurological disorders Jun-ichi Kira (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) / Kazuhiro Ikenaka (Division of Neurobiology and Bioinformatics National Institute for Physiological Sciences) Kazuhiro Ikenaka (Division of Neurobiology and Bioinformatics National Institute for Physiological Sciences) Oligodendrocyte-neuron interaction in physiological and pathological states
Jun-ichi Kira (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) Disruption of glia-neuron assemblies in an intractable neurological disorder
Junichi Nabekura (National Institute for Physiological Science) Remodeling of Cortical Neuronal Circuits in vivo: Synapse-Microglia Interaction
Hiroshi Nakanishi (Department of Aging Science and Pharmacology, Faculty of Dental Science, Kyushu University) Emerging roles of microglial cathepsins in intractable neurological disorders
May 20 (Friday) 13:15-14:55
Room15(Kobe International Conference Center[Meeting Room502] 5F) S-16 Pathomechanisms and therapeutic intervention of abnormal excitability in the upper and lower motor neuron systems Hiroyuki Nodera (Department of Neurology, Tokushima Univeristy)/ Hugh Bostock (University College London) Hugh Bostock (Institute of Neurology, University College London) Muscle Excitability
Cindy Shin-yi Lin (The University of New South Wales) Hyperexcitability and ALS: Past, present and future
Hiroyuki Nodera (Department of Neurology, Tokushima Univeristy) Sodium channelopathy in disuse neuromyopathy
Yusuke Osaki (Department of Neurology, Institute of Biomedical Sciences, Tokushima University Graduate School) Peripheral nerve excitability abnormality in spinocerebellar ataxia type 6

WFN Session

Vetue No. Theme Chair Speaker Title
May 20 (Friday) 8:00-10:00
Room5(Kobe International Exhibition Hall[Room 2A] Hall No.2 Building 3F) WFN Priorities in Neurology: Global Perspective Terrence Lawrence Cascino (American Academy of Neurology) / Raad Shakir (Brain Science Imperial College London UK) Raad Shakir (Brain Science Imperial College London UK) Priorities in Neurology: a global perspective.
Man Mohan Mehndiratta (Director, Professor & HOD, Department of Neurology, Janakpuri Superspecialty Hospital, Janakpuri, New DELHI-110058) Neurological education and care in Asian and Oceanian region
Byung Chul Lee (Department of Neurology, Hallym University Sacred Heart Hospital Hallym University College of Medicine/Senior Vice President of Hallym Medical Center/Director, Korean Society of Cardiovascular Disease Prevention/President, Korean Neurological Association) Current Status of Acute Ischemic Stroke Care in Korea:
Dede Gunawan (ASEAN Neurological Association) South East Asia
Amadou GALLO Diop (University of Dakar, SENEGAL) EXAMPLES OF THE MANAGEMENT OF EPILEPSY AND STROKE IN SUB-SAHARAN AFRICA: REALITY and CHALLENGES
Marco Medina (WFN Latin American Regional Director and Dean of the Faculty of Medical Sciences, National Autonomous University of Honduras) The Pan-American Federation of Neurological Societies (PAFNS): A new Regional Organization
Renato J. Verdugo (Service of Neurology, Faculty of Medicine, Clinica Alemana-Universidad del Desarrollo, Chile) Priorities in Neurology: Latin America

International Educational Session

Vetue No. Theme Chair Speaker Title
May 18 (Wednesday) 13:15-15:15
Room22(Kobe International Conference Center [Meeting Room505] 5F) IE-01 Multiple sclerosis William M. Carroll (Dept Neurology Sir Charles Gairdner Hospital/Western Australian Neuromuscular Research Institute/Centre for Neuromuscular and Neurological Disorders/University of Western Australia/Queen Elizabeth II Medical Centre) / Dede Gunawan (Department of Neurology, Padjadjaran University, Hasan Sadikin Hospital) William M. Carroll (Dept Neurology Sir Charles Gairdner Hospital/Western Australian Neuromuscular Research Institute/Centre for Neuromuscular and Neurological Disorders/University of Western Australia/Queen Elizabeth II Medical Centre) Recent advances in the treatment of multiple sclerosis.
Saeed Abdulla. Bohlega(King Faisal Specialist Hospital & Research Centre) Epidemiology of Multiple Sclerosis in the Arab Region
Jun-ichi Kira(Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) Factors associated with susceptibility to and clinical features of multiple sclerosis in Japanese
Ching-Piao Tsai(Neurological Institute, Taipei Veterans General Hospital and National Yang Ming University) Multiple Sclerosis in Taiwan, increased prevalence and changing clinical characteristics.
Riadh Gouider(Neurology Department, Razi Hospital, Research Unit UR 12 SP 21, Tunis, Tunisia) Multiple Sclerosis in Africa
May 19 (Thursday) 8:00-10:00
Room16(Kobe International Conference Center[Meeting Room403] 4F) IE-02 How to diagnose and treat MMN, an ALS mimic Austin Sumner (LSU Health Sciences Center) / Jean-Marc Leger (University Hospital Pitié-Salpêtrière and University Pierre et Marie Curie (Paris 6)) Austin J. Sumner (LSU Health Sciences Center) Multifocal Motor Neuropathy
Hiroyuki Nodera (Department of Neurology, Tokushima University) Electrophysiology and imaging techniques for diagnosis of MMN
Hugh Bostock (University College London) Nerve excitability studies and the pathophysiology of MMN: a reappraisal
Jean-Marc Leger (University Hospital Pitié-Salpêtrière and University Pierre et Marie Curie (Paris 6)) Update in short and long-term therapy of mutifocal motor neuropathy
May 19 (Thursday) 15:15-17:15
Room16(Kobe International Conference Center[Meeting Room403] 4F) IE-03 How to Manage Seizures Byung-In Lee (Department of Neurology, Inje University School of Medicine) / Kiyohito Terada (Department of Epileptology, Shizuoka Institute of Epilepsy and Neurological Disorders) Byung-In Lee (Department of Neurology, Inje University School of Medicine) When and What is Epilepsy?
Kiyohito Terada (Department of Epileptology, Shizuoka Institute of Epilepsy and Neurological Disorders) Electroencephalography in Epilepsy
Kheng-Seang Lim (University of Malaya, Malaysia) Imaging in Epilepsy
Naoki Akamatsu (International University of Health and Welfare School of Health Sciences at Fukuoka) Treatment of seizures
Akio Ikeda (Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine) Uncommon, but important causes of epilepsy and seizure
May 20 (Friday) 8:00-10:00
Room11(Kobe International Conference Center[International Conference Hall] 3・4F) IE-04 Movement Disorders Video Session Mitsutoshi Yamamoto(Takamatsu Neurology Clinic/Takamatsu Institute for Parkinson Disease) /Beomseok Jeon(Department of Neurology and Movement Disorder Center, Parkinson Study Group, Seoul National University Hospital) Beomseok Jeon (Department of Neurology and Movement Disorder Center, Parkinson Study Group, Seoul National University Hospital) Video vignettes in the diagnosis of Parkinson Disease
Werner Poewe(Dept. of Neurology, Innsbruck Medical University) Non PD parkinsonism: a diagnostic challenge
Raymond Lotilla Rosales(University of Santo Tomas Hospital, Manila, Philippines) Is this Spasticity, Dystonia, Both or Neither?
Mitsutoshi Yamamoto (Takamatsu Neurology Clinic/Takamatsu Institute for Parkinson Disease) Hyperkinetic disorders
Hiroshi Shibasaki(Kyoto University Graduate School of Medicine) Clinical Classification of Myoclonus
Louis Tan (National Neuroscience Institute, Singapore) Paroxysmal Dyskinesias
May 20 (Friday) 8:00-10:00
Room16(Kobe International Conference Center[Meeting Room403] 4F) IE-05 Spasticity: A Common But Under-Recognized Condition John Rothwell (Human Neurophysiology, UCL Institute of Neurology) /Kimiyoshi Arimura(Okatsu Neurology and Rehabilitation Hospital) John Rothwell (Human Neurophysiology, UCL Institute of Neurology) Physiology of post-stroke spasticity
Leonard S.W.. Li (The Univeristy of Hong Kong) Management of Post-Stroke Spasticity
Kimiyoshi Arimura (Okatsu Neurology and Rehabilitation Hospital) Practice of Botulinum Toxin Injection
Yoshiyuki Sankai (Graduate School of Systems and Information Engineering, University of Tsukuba / Center for Cybernics Research, University of Tsukuba / Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Program, JST / CYBERDYNE Inc) Dawn of Cybernic Neuro-rehabiliation: Combined Treatment with HAL and Botulinum Toxin Injection
May 20 (Friday) 13:15-15:15
Room16(Kobe International Conference Center[Meeting Room403] 4F) IE-06 Emerging Therapies in ALS Hiroshi Mitsumoto(Eleanor and Lou Gehrig MDA/ALS Center, Department of Neurology, Columbia University Medical Center) /Koji Abe(Department of Neurology, Okayama University) Hiroshi Mitsumoto(Eleanor and Lou Gehrig MDA/ALS Center, Department of Neurology, Columbia University Medical Center) Randomized Clinical Trials (RCT) in ALS: A Turning Point
Ken Ikeda(Department of Neurology, Toho University Omori Medical Center) Therapeutic Development using Wobbler Mouse, an Animal Model of ALS
Koji Abe(Department of Neurology, Okayama University) Mechanism of ALS and the clinical neuroprotection in Japan
Yuishin Izumi(Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School) Clinical trials of ultra-high dose methylcobalamin in ALS
Seung Hyun Kim(Hanyang University Hospital, Seoul, Korea) PHASE I/II TRIALS OF AUTOLOGOUS BM DERIVED STEM CELL THERAPY IN AMYOTROPHIC LATERAL SCLEROSIS

Special Educational Course

Vetue No. Theme Chair Speaker Title
May 18 (Wednesday) 9:50-11:50
Room12(Kobe International Conference Center[Reception Hall] 3F) SE-01 EMG Hands-On Toshiaki Hamano (Department of Neurology, Kansai Electric Power Hospital) / Nobuyuki Hirota (Department of Neurology, Otsu Municipal Hospital) Jun Kimura(University of Iowa Health Care, USA) -
Hugh Bostock(University College London) Threshold tracking
May 18 (Wednesday) 13:15-15:15
Room16(Kobe International Conference Center[Meeting Room403] 4F) SE-02 How to write an English Paper Akira Tamaoka (Department of Neurology, University of Tsukuba) Shoji Tsuji (Department of Neurology, The University of Tokyo) -